Alternative Links zum Volltext:
| Dokumentenart: | Artikel | ||||
|---|---|---|---|---|---|
| Titel eines Journals oder einer Zeitschrift: | Archiv der Pharmazie (Weinheim, Germany) | ||||
| Band: | 328 | ||||
| Nummer des Zeitschriftenheftes oder des Kapitels: | 9 | ||||
| Seitenbereich: | S. 645-653 | ||||
| Datum: | 1995 | ||||
| Zusätzliche Informationen (Öffentlich): | CAN 124:336 1-6 Pharmacology 163168-43-2 Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), BIOL (Biological study) (prepn., stability, and antitumor activity of parenterally administrable hydrosol of [bis(fluorophenyl)ethylenediamine]dichloroplatinum(II); 125948-98-3 Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), RCT (Reactant), BIOL (Biological study), RACT (Reactant or reagent) (prepn., stability, and antitumor activity of parenterally administrable hydrosol of [bis(fluorophenyl)ethylenediamine]dichloroplatinum(II); 105990-74-7P Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), SPN (Synthetic preparation), THU (Therapeutic use), BIOL (Biological study), PREP (Preparation), USES (Uses) (prepn., stability, and antitumor activity of parenterally administrable hydrosol of [bis(fluorophenyl)ethylenediamine]dichloroplatinum(II); 7647-14-5 (Sodium chloride); 106392-12-5 (Pluronic F 68) Role: BUU (Biological use, unclassified), BIOL (Biological study), USES (Uses) (prepn., stability, and antitumor activity of parenterally administrable hydrosol of [bis(fluorophenyl)ethylenediamine]dichloroplatinum(II) | ||||
| Institutionen: | Chemie und Pharmazie > Institut für Pharmazie > Entpflichtete oder im Ruhestand befindliche Professoren > Prof. Schönenberger Chemie und Pharmazie > Institut für Pharmazie > Lehrstuhl Pharmazeutische / Medizinische Chemie II (Prof. Buschauer) | ||||
| Identifikationsnummer: |
| ||||
| Stichwörter / Keywords: | Pharmaceutical dosage forms (hydrosols, prepn., stability, and antitumor activity of parenterally administrable hydrosol of [bis(fluorophenyl)ethylenediamine]dichloroplatinum(II); Neoplasm inhibitors (mammary gland, prepn., stability, and antitumor activity of parenterally administrable hydrosol of [bis(fluorophenyl)ethylenediamine]dichloroplatinum(II); Mammary gland (neoplasm, inhibitors, prepn., stability, and antitumor activity of parenterally administrable hydrosol of [bis(fluorophenyl)ethylenediamine]dichloroplatinum(II); platinum complex prepn stability neoplasm inhibition; fluorophenylethylenediaminedichloroplatinum complex prepn stability neoplasm inhibition | ||||
| Dewey-Dezimal-Klassifikation: | 500 Naturwissenschaften und Mathematik > 570 Biowissenschaften, Biologie 500 Naturwissenschaften und Mathematik > 540 Chemie | ||||
| Status: | Veröffentlicht | ||||
| Begutachtet: | Ja, diese Version wurde begutachtet | ||||
| An der Universität Regensburg entstanden: | Zum Teil | ||||
| Dokumenten-ID: | 5477 |
Zusammenfassung
The development of a galenical formulation for poorly water sol. dichloroplatinum(II) complexes suitable for the parenteral administration in cancer chemotherapy is described. The procedure, which we elaborated for [(+-)-1,2-bis(4-fluorophenyl)ethylenediamine]dichloroplatinum(II) (rac-4F-PtCl2), is based on the reaction of a sol. diaquaplatinum(II) salt with sodium chloride in water in the ...
Zusammenfassung
The development of a galenical formulation for poorly water sol. dichloroplatinum(II) complexes suitable for the parenteral administration in cancer chemotherapy is described. The procedure, which we elaborated for [(+-)-1,2-bis(4-fluorophenyl)ethylenediamine]dichloroplatinum(II) (rac-4F-PtCl2), is based on the reaction of a sol. diaquaplatinum(II) salt with sodium chloride in water in the presence of pluronic F 68 as stabilizer and results in a sufficiently stable colloidal soln. (i.e. hydrosol). In contrast to the poorly water sol. synthetic rac-4F-PtCl2, which was ineffective towards the hormone sensitive MXt-M-3.2 breast cancer of the mouse, its hydrosol formulation proved to be highly active and was very well tolerated.
Metadaten zuletzt geändert: 24 Mai 2018 10:10
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Altmetric